TP53 and breast cancer: In agreement with our findings, the very recent landmark analysis of somatic mutations detected in 560 human breast cancers did not find any mutations in the SYK gene [37], compared to highly significant mutation rates for the known proto-oncogenes TP53 and PTEN.